Effect of Self-management Intervention on Cortisol and Daily Stress Levels in Irritable Bowel Syndrome

Overview

Journal Biol Res Nurs

Specialties Biology
Nursing

Date 2011 Jul 19

PMID 21765120

Citations 8

Authors

Wimon Deechakawan

Kevin C Cain

Monica E Jarrett

Robert L Burr

Margaret M Heitkemper

Affiliations

Soon will be listed here.

Abstract

Self-management programs that include cognitive behavioral strategies have been shown to improve gastrointestinal (GI) symptoms, psychological distress, and quality of life (QoL) in persons with irritable bowel syndrome (IBS). However, less is known about the physiological impact of such a change. As part of a randomized controlled trial using a comprehensive self-management (CSM) intervention (n = 126) compared to usual care (UC; n = 62), cortisol levels were measured in 4 weekly first morning urine samples at baseline and at 3-, 6-, and 12-month follow-up. In addition, diary (28 days) ratings of stress were recorded at baseline, 3, 6, and 12 months. The omnibus test of all three outcome times showed no differences in urine cortisol levels between the CSM and UC groups (p = .400); however, at 3 months the CSM group had significantly higher cortisol levels than the UC group (p = .012). The CSM group reported lower daily stress levels (p = .046 from the omnibus test of all 3 time points) than the UC group, with the effect getting stronger over time. Despite marked improvements in reported stress and previously reported GI and psychological distress symptoms at later follow-ups, the CSM program did not reduce urine cortisol levels in adults with IBS. These results suggest that the first-void urine cortisol levels are not reflective of self-reported daily stress in this patient population.

Citing Articles

A Biofeedback-Assisted Stress Management Program for Patients with Irritable Bowel Syndrome: a Randomised Controlled Trial.

Exarchopoulou K, Papageorgiou A, Bacopoulou F, Koumantarou Malisiova E, Vlachakis D, Chrousos G EMBnet J. 2021; 26.

PMID: 34722218 PMC: 8553100. DOI: 10.14806/ej.26.1.980.

Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.

Cong X, Perry M, Bernier K, Young E, Starkweather A West J Nurs Res. 2017; 40(11):1698-1720.

PMID: 28854852 PMC: 5794643. DOI: 10.1177/0193945917727705.

Irritable Bowel Syndrome.

Weaver K, DEramo Melkus G, Henderson W Am J Nurs. 2017; 117(6):48-55.

PMID: 28541989 PMC: 5453305. DOI: 10.1097/01.NAJ.0000520253.57459.01.

Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial.

Jang A, Hwang S, Padhye N, Meininger J J Neurogastroenterol Motil. 2017; 23(3):435-445.

PMID: 28480684 PMC: 5503294. DOI: 10.5056/jnm17017.

Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms.

Edebol-Carlman H, Ljotsson B, Linton S, Boersma K, Schrooten M, Repsilber D Gastroenterol Res Pract. 2017; 2017:8915872.

PMID: 28210270 PMC: 5292189. DOI: 10.1155/2017/8915872.

References

Nyrop K, Palsson O, Levy R, von Korff M, Feld A, Turner M . Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007; 26(2):237-48. DOI: 10.1111/j.1365-2036.2007.03370.x. View

Schmulson M, Adeyemo M, Gutierrez-Reyes G, Charua-Guindic L, Farfan-Labonne B, Ostrosky-Solis F . Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol. 2010; 105(4):925-32. DOI: 10.1038/ajg.2010.58. View

Jarrett M, Cain K, Burr R, Hertig V, Rosen S, Heitkemper M . Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions. Am J Gastroenterol. 2009; 104(12):3004-14. PMC: 2804069. DOI: 10.1038/ajg.2009.479. View

Lackner J, Mesmer C, Morley S, Dowzer C, Hamilton S . Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004; 72(6):1100-13. DOI: 10.1037/0022-006X.72.6.1100. View

Matousek R, Dobkin P, Pruessner J . Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010; 16(1):13-9. DOI: 10.1016/j.ctcp.2009.06.004. View

Heitkemper M, Jarrett M . Update on irritable bowel syndrome and gender differences. Nutr Clin Pract. 2008; 23(3):275-83. DOI: 10.1177/0884533608318672. View

Rao K . Recent research in stress, coping and women's health. Curr Opin Psychiatry. 2009; 22(2):188-93. DOI: 10.1097/YCO.0b013e328320794a. View

Mulak A, Bonaz B . Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit. 2004; 10(4):RA55-62. View

Woods N, Mitchell E . Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep. 2010; 33(4):539-49. PMC: 2849794. DOI: 10.1093/sleep/33.4.539. View

10.

Murray C, Flynn J, Ratcliffe L, Jacyna M, Kamm M, Emmanuel A . Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology. 2004; 127(6):1695-703. DOI: 10.1053/j.gastro.2004.08.057. View

11.

Ehlert U, Nater U, Bohmelt A . High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. J Psychosom Res. 2005; 59(1):7-10. DOI: 10.1016/j.jpsychores.2005.03.005. View

12.

Galvin J, Benson H, Deckro G, Fricchione G, Dusek J . The relaxation response: reducing stress and improving cognition in healthy aging adults. Complement Ther Clin Pract. 2006; 12(3):186-91. DOI: 10.1016/j.ctcp.2006.02.004. View

13.

Elsenbruch S, Lucas A, Holtmann G, Haag S, Gerken G, Riemenschneider N . Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol. 2006; 101(10):2300-7. DOI: 10.1111/j.1572-0241.2006.00837.x. View

14.

Hertig V, Cain K, Jarrett M, Burr R, Heitkemper M . Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs Res. 2007; 56(6):399-406. DOI: 10.1097/01.NNR.0000299855.60053.88. View

15.

Chang L, Sundaresh S, Elliott J, Anton P, Baldi P, Licudine A . Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2008; 21(2):149-59. PMC: 2745840. DOI: 10.1111/j.1365-2982.2008.01171.x. View

16.

Brun-Strang C, Dapoigny M, Lafuma A, Wainsten J, Fagnani F . Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. Eur J Gastroenterol Hepatol. 2007; 19(12):1097-103. DOI: 10.1097/MEG.0b013e3282f1621b. View

17.

FitzGerald L, Kehoe P, Sinha K . Hypothalamic--pituitary-- adrenal axis dysregulation in women with irritable bowel syndrome in response to acute physical stress. West J Nurs Res. 2009; 31(7):818-36. DOI: 10.1177/0193945909339320. View

18.

Whitehead W, Crowell M, Robinson J, Heller B, SCHUSTER M . Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992; 33(6):825-30. PMC: 1379344. DOI: 10.1136/gut.33.6.825. View

19.

Mayer E, Craske M, Naliboff B . Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry. 2002; 62 Suppl 8:28-36; discussion 37. View

20.

Chang L, Mayer E, Labus J, Schmulson M, Lee O, Olivas T . Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome. Am J Physiol Regul Integr Comp Physiol. 2006; 291(2):R277-84. DOI: 10.1152/ajpregu.00729.2005. View